https://news.medxy.ai/zh/breathlessness-in-cchs/Medxy AIzh2026-10-28T02:26:24-07:00揭示成人先天性中枢性低通气综合征的呼吸感受：静息与CO2重复吸入过程中的呼吸困难特征分析 https://news.medxy.ai/ja/breathing-sensation-in-cchs/Medxy AIja2026-10-28T02:25:51-07:00安静時とCO2再呼吸から読み解く、成人先天性中枢性低換気症候群における呼吸感覚の実態 https://news.medxy.ai/vi/breathing-sensation-study/Medxy AIvi2026-10-28T02:25:10-07:00Khám phá cảm giác hô hấp ở người lớn mắc hội chứng giảm thông khí trung ương bẩm sinh: hiểu biết từ phân tích dyspnea trong lúc nghỉ và tái hít CO2 https://news.medxy.ai/unveiling-respiratory-sensations-in-adults-with-congenital-central-hypoventilation-syndrome-insights-from-dyspnea-profiling-during-rest-and-co2-rebreathing/Medxy AIen2026-10-28T02:24:44-07:00Unveiling Respiratory Sensations in Adults with Congenital Central Hypoventilation Syndrome: Insights from Dyspnea Profiling During Rest and CO2 Rebreathing https://news.medxy.ai/zh/contact-lenses-fungal-keratitis-outcomes/Medxy AIzh2026-10-28T02:23:59-07:00隐形眼镜使用对真菌性角膜炎临床结局的影响：一项8年回顾性研究的启示 https://news.medxy.ai/ja/contact-lenses-fungal-keratitis-8-years-outcomes/Medxy AIja2026-10-28T02:23:36-07:00コンタクトレンズ使用が真菌性角膜炎の臨床転帰に及ぼす影響：8年間の後ろ向き研究からの示唆 https://news.medxy.ai/vi/clinical-impact-fungal-keratitis/Medxy AIvi2026-10-28T02:23:07-07:00Tác động lâm sàng của việc sử dụng kính áp tròng trong viêm giác mạc do nấm: Phân tích hồi cứu 8 năm https://news.medxy.ai/clinical-impact-of-contact-lens-use-in-fungal-keratitis-insights-from-an-8-year-retrospective-study/Medxy AIen2026-10-28T02:22:40-07:00Clinical Impact of Contact Lens Use in Fungal Keratitis: Insights from an 8-Year Retrospective Study https://news.medxy.ai/zh/bpd-neurodevelopment-prediction/Medxy AIzh2026-10-28T02:21:57-07:00重度BPD神经发育结局预测：气管插管持续时间比气管切开更关键 https://news.medxy.ai/ja/intubation-duration-neurodevelopment/Medxy AIja2026-10-28T02:21:34-07:00重症BPDでは気管切開よりも挿管期間が神経発達予後を左右する https://news.medxy.ai/vi/prolonged-intubation-neurodevelopment/Medxy AIvi2026-10-28T02:21:04-07:00Đặt nội khí quản kéo dài dự báo kết cục phát triển thần kinh ở BPD nặng tốt hơn mở khí quản https://news.medxy.ai/intubation-duration-trumps-tracheostomy-in-predicting-neurodevelopmental-outcomes-in-severe-bpd/Medxy AIen2026-10-28T02:20:40-07:00Intubation Duration Trumps Tracheostomy in Predicting Neurodevelopmental Outcomes in Severe BPD https://news.medxy.ai/zh/temporary-portal-vein-bypass/Medxy AIzh2026-10-28T02:19:54-07:00胰腺切除术中的临时门静脉旁路：提升复杂胰腺癌手术安全性 https://news.medxy.ai/ja/temporary-portal-vein-bypass-3/Medxy AIja2026-10-28T02:19:26-07:00膵切除における一時的門脈バイパス：複雑な膵癌手術の安全性を高める https://news.medxy.ai/vi/temporary-portal-vein-bypass-2/Medxy AIvi2026-10-28T02:18:57-07:00Bắc cầu tĩnh mạch cửa tạm thời trong phẫu thuật cắt tụy: Tăng cường độ an toàn cho phẫu thuật ung thư tụy phức tạp https://news.medxy.ai/temporary-portal-vein-bypass-in-pancreatectomy-enhancing-safety-in-complex-pancreatic-cancer-surgery/Medxy AIen2026-10-28T02:18:31-07:00Temporary Portal Vein Bypass in Pancreatectomy: Enhancing Safety in Complex Pancreatic Cancer Surgery https://news.medxy.ai/zh/optimizing-steroid-tapering-strategies/Medxy AIzh2026-10-28T02:17:52-07:00妇科肿瘤免疫治疗毒性管理中糖皮质激素减量策略的优化 https://news.medxy.ai/ja/optimizing-steroid-tapering-strategies-2/Medxy AIja2026-10-28T02:17:20-07:00婦人科癌における免疫療法毒性へのステロイド漸減戦略を最適化する https://news.medxy.ai/vi/steroid-tapering-strategy/Medxy AIvi2026-10-28T02:16:48-07:00Tối ưu chiến lược giảm liều steroid trong xử trí độc tính của liệu pháp miễn dịch ở ung thư phụ khoa https://news.medxy.ai/optimizing-steroid-tapering-strategies-for-immunotherapy-toxicities-in-gynecologic-cancers/Medxy AIen2026-10-28T02:16:17-07:00Optimizing Steroid Tapering Strategies for Immunotherapy Toxicities in Gynecologic Cancers https://news.medxy.ai/zh/integrated-treatment-alcoholic-hepatitis/Medxy AIzh2026-10-28T02:15:31-07:00酒精相关性肝炎临床试验中的酒精使用障碍整合治疗：以复合终点推动结局优化 https://news.medxy.ai/ja/integrated-addiction-treatment-trials/Medxy AIja2026-10-28T02:15:06-07:00アルコール関連肝炎の臨床試験における依存症治療の統合：転帰改善に向けた複合エンドポイントの発展 https://news.medxy.ai/vi/integrated-alcohol-treatment-trials/Medxy AIvi2026-10-28T02:14:26-07:00Tích hợp điều trị rối loạn sử dụng rượu trong các thử nghiệm lâm sàng viêm gan do rượu: thúc đẩy tiêu chí đánh giá tổng hợp để cải thiện kết cục https://news.medxy.ai/integrating-therapies-for-alcohol-use-disorder-in-alcohol-associated-hepatitis-clinical-trials-advancing-composite-endpoints-for-improved-outcomes/Medxy AIen2026-10-28T02:13:58-07:00Integrating Therapies for Alcohol Use Disorder in Alcohol-Associated Hepatitis Clinical Trials: Advancing Composite Endpoints for Improved Outcomes https://news.medxy.ai/zh/brain-atrophy-progression-in-multiple-sclerosis/Medxy AIzh2026-10-28T02:13:22-07:00多发性硬化症、MOGAD及AQP4阳性NMOSD中脑萎缩的不同演变轨迹：解读MOGAD中疾病活动度的影响 https://news.medxy.ai/ja/brain-atrophy-progression-in-neuroinflammatory-diseases/Medxy AIja2026-10-28T02:12:52-07:00多発性硬化症・MOGAD・AQP4陽性NMOSDにおける脳萎縮の異なる推移：MOGADにおける疾患活動性の影響を読み解く https://news.medxy.ai/differential-trajectories-of-brain-atrophy-in-multiple-sclerosis-mogad-and-aqp4-nmosd-unraveling-the-impact-of-disease-activity-in-mogad/Medxy AIen2026-10-28T02:11:44-07:00Differential Trajectories of Brain Atrophy in Multiple Sclerosis, MOGAD, and AQP4+ NMOSD: Unraveling the Impact of Disease Activity in MOGAD https://news.medxy.ai/zh/low-carb-diet-in-gestational-diabetes-digest/Medxy AIzh2026-10-28T02:10:54-07:00妊娠期糖尿病中的低碳水化合物饮食：营养充足性、血糖控制及围产期结局——基于DiGest试验 https://news.medxy.ai/vi/low-carb-gestational-diabetes/Medxy AIvi2026-10-28T02:09:44-07:00Chế độ ăn ít carbohydrate trong đái tháo đường thai kỳ: đầy đủ dinh dưỡng, kiểm soát đường huyết và kết cục chu sinh dưới góc nhìn thử nghiệm DiGest và bằng chứng hiện có https://news.medxy.ai/low-carbohydrate-diets-nutritional-adequacy-glycemia-and-perinatal-outcomes-in-women-with-gestational-diabetes-mellitus-insights-from-the-digest-trial-and-contemporary-evidence/Medxy AIen2026-10-28T02:09:12-07:00Low-Carbohydrate Diets, Nutritional Adequacy, Glycemia, and Perinatal Outcomes in Women With Gestational Diabetes Mellitus: Insights from the DiGest Trial and Contemporary Evidence https://news.medxy.ai/zh/hip-arthroscopy-fais-treatment/Medxy AIzh2026-10-28T02:08:16-07:00现代髋关节镜助力竞技运动员FAIS治疗：结局更佳，重返赛场率更高 https://news.medxy.ai/ja/improved-hip-arthroscopy-outcomes/Medxy AIja2026-10-28T02:07:49-07:00FAISに対する現代的股関節鏡視下手術で、競技復帰率と治療成績が向上 https://news.medxy.ai/vi/improved-hip-arthroscopy-outcomes-2/Medxy AIvi2026-10-28T02:07:15-07:00Kết quả cải thiện và tỷ lệ trở lại thi đấu cao hơn ở vận động viên thi đấu được nội soi khớp háng hiện đại vì hội chứng va chạm ổ cối–chỏm xương đùi https://news.medxy.ai/enhanced-outcomes-and-return-to-sport-rates-in-competitive-athletes-undergoing-contemporary-hip-arthroscopy-for-femoroacetabular-impingement-syndrome/Medxy AIen2026-10-28T02:06:46-07:00Enhanced Outcomes and Return-to-Sport Rates in Competitive Athletes Undergoing Contemporary Hip Arthroscopy for Femoroacetabular Impingement Syndrome https://news.medxy.ai/zh/companionship-in-spinal-cord-injury/Medxy AIzh2026-10-28T02:06:05-07:00陪伴感在脊髓损伤患者心理社会健康中的关键作用 https://news.medxy.ai/ja/companionship-after-spinal-injury/Medxy AIja2026-10-28T02:05:42-07:00脊髄損傷者の心理社会的健康を支える「同伴感」の重要性 https://news.medxy.ai/vi/companionship-improves-mental-health/Medxy AIvi2026-10-28T02:05:06-07:00Đồng hành: yếu tố then chốt cải thiện sức khỏe tâm lý xã hội ở người bị tổn thương tủy sống https://news.medxy.ai/companionships-crucial-role-in-enhancing-psychosocial-health-among-individuals-with-spinal-cord-injury/Medxy AIen2026-10-28T02:04:42-07:00Companionship’s Crucial Role in Enhancing Psychosocial Health Among Individuals with Spinal Cord Injury https://news.medxy.ai/zh/horizontal-ridge-augmentation/Medxy AIzh2026-10-28T02:04:06-07:00水平牙槽嵴增量的新思路：负载rhBMP-2的体积稳定胶原基质能否优于引导骨再生？ https://news.medxy.ai/ja/horizontal-ridge-augmentation-2/Medxy AIja2026-10-28T02:03:39-07:00rhBMP-2含浸体積安定性コラーゲンマトリックスによる水平的歯槽堤増大：GBRとの比較 https://news.medxy.ai/vi/88216-2-88216/Medxy AIvi2026-10-28T02:03:06-07:00Tăng thể tích sống hàm theo chiều ngang bằng ma trận collagen ổn định thể tích có tẩm rhBMP-2: So sánh với kỹ thuật GBR https://news.medxy.ai/enhancing-horizontal-ridge-augmentation-efficacy-of-rhbmp-2-loaded-volume-stable-collagen-matrix-versus-guided-bone-regeneration/Medxy AIen2026-10-28T02:02:36-07:00Enhancing Horizontal Ridge Augmentation: Efficacy of rhBMP-2 Loaded Volume-Stable Collagen Matrix Versus Guided Bone Regeneration https://news.medxy.ai/zh/atorvastatin-older-adults/Medxy AIzh2026-10-28T02:01:52-07:00老年人应用阿托伐他汀：平衡心血管预防与无残疾生存 https://news.medxy.ai/ja/atorvastatin-older-adults-2/Medxy AIja2026-10-28T02:01:28-07:00高齢者におけるアトルバスタチン：心血管予防と障害なし生存の両立をどう考えるか https://news.medxy.ai/vi/atorvastatin-elderly-disability-free-living/Medxy AIvi2026-10-28T02:01:03-07:00Atorvastatin ở người cao tuổi: Cân bằng giữa dự phòng tim mạch và sống không tàn tật https://news.medxy.ai/atorvastatin-in-older-adults-balancing-cardiovascular-prevention-and-disability-free-survival/Medxy AIen2026-10-28T02:00:40-07:00Atorvastatin in Older Adults: Balancing Cardiovascular Prevention and Disability-Free Survival https://news.medxy.ai/zh/hemithyroidectomy-pregnancy-outcomes/Medxy AIzh2026-10-28T01:56:21-07:00半甲状腺切除术对妊娠期甲状腺功能减退及妊娠结局的影响：基于全国匹配队列的研究 https://news.medxy.ai/ja/thyroidectomy-pregnancy-outcomes/Medxy AIja2026-10-28T01:55:55-07:00片葉甲状腺切除術は妊娠転帰にどう影響するか：全国マッチドコホート研究からみた妊娠性甲状腺機能低下症と合併症 https://news.medxy.ai/vi/thyroidectomy-pregnancy-outcomes-2/Medxy AIvi2026-10-28T01:55:24-07:00Cắt một thùy tuyến giáp có ảnh hưởng gì đến suy giáp thai kỳ và kết cục thai kỳ? Bằng chứng từ một đoàn hệ ghép cặp toàn quốc https://news.medxy.ai/implications-of-hemithyroidectomy-on-gestational-hypothyroidism-and-pregnancy-outcomes-insights-from-a-nationwide-matched-cohort/Medxy AIen2026-10-28T01:54:59-07:00Implications of Hemithyroidectomy on Gestational Hypothyroidism and Pregnancy Outcomes: Insights from a Nationwide Matched Cohort https://news.medxy.ai/zh/c-reactive-protein-heart-failure-recovery/Medxy AIzh2026-10-28T01:54:19-07:00C反应蛋白或可预测老年心衰住院患者康复获益：体能改善与基线炎症水平密切相关 https://news.medxy.ai/ja/crp-predicts-rehabilitation-outcomes/Medxy AIja2026-10-28T01:53:56-07:00炎症バイオマーカーCRPが、高齢心不全入院患者におけるリハビリ効果を予測 https://news.medxy.ai/vi/crp-inflammation-heart-failure-rehabilitation/Medxy AIvi2026-10-28T01:53:30-07:00CRP – dấu ấn viêm dự báo mức cải thiện chức năng từ phục hồi chức năng ở người cao tuổi nhập viện vì suy tim https://news.medxy.ai/inflammation-biomarker-crp-predicts-functional-gains-from-physical-rehabilitation-in-older-adults-hospitalized-with-heart-failure/Medxy AIen2026-10-28T01:53:07-07:00Inflammation Biomarker CRP Predicts Functional Gains from Physical Rehabilitation in Older Adults Hospitalized with Heart Failure https://news.medxy.ai/ja/reassessing-functional-independence/Medxy AIja2026-10-28T01:52:26-07:00機能的自立評価の再構築：混合サンプルにおける現代版拡大日常生活動作尺度の妥当性検証 https://news.medxy.ai/vi/modern-functional-independence-measurement/Medxy AIvi2026-10-28T01:52:03-07:00Hiện đại hóa đo lường khả năng độc lập chức năng: Thẩm định thang Contemporary Extended Activities of Daily Living trên một mẫu hỗn hợp https://news.medxy.ai/modernising-functional-independence-measurement-validation-of-a-contemporary-extended-activities-of-daily-living-scale-in-a-mixed-sample/Medxy AIen2026-10-28T01:51:41-07:00Modernising Functional Independence Measurement: Validation of a Contemporary Extended Activities of Daily Living Scale in a Mixed Sample https://news.medxy.ai/zh/3d-printed-dentures-follow-up/Medxy AIzh2026-10-28T01:51:03-07:003D打印全口义齿2年随访结果：无牙颌修复中的疗效与患者满意度 https://news.medxy.ai/ja/3d-printed-dentures-outcomes/Medxy AIja2026-10-28T01:50:39-07:003Dプリント全部床義歯の2年成績：無歯顎補綴における有効性と患者満足度 https://news.medxy.ai/vi/3d-printed-dentures-follow-up-outcome/Medxy AIvi2026-10-28T01:50:03-07:00Kết quả sau 2 năm sử dụng hàm giả toàn hàm in 3D: Hiệu quả và mức độ hài lòng của bệnh nhân trong phục hình cho người mất răng toàn bộ https://news.medxy.ai/two-year-outcomes-of-3d-printed-complete-dentures-efficacy-and-patient-satisfaction-in-edentulous-care/Medxy AIen2026-10-28T01:49:38-07:00Two-Year Outcomes of 3D-Printed Complete Dentures: Efficacy and Patient Satisfaction in Edentulous Care https://news.medxy.ai/zh/deucrictibant-hereditary-angioedema-attack-treatment/Medxy AIzh2026-10-28T01:48:56-07:00口服 deucrictibant 按需治疗遗传性血管性水肿发作：Ⅲ期多中心随机双盲安慰剂对照交叉试验及相关证据 https://news.medxy.ai/ja/hereditary-angioedema-treatment/Medxy AIja2026-10-28T01:48:18-07:00遺伝性血管性浮腫発作の発作時治療における経口デュクリキティバント：第3相多施設共同ランダム化二重盲検プラセボ対照クロスオーバー試験と関連エビデンス https://news.medxy.ai/vi/oral-deucrictibant-hereditary-angioedema/Medxy AIvi2026-10-28T01:47:34-07:00Deucrictibant đường uống trong điều trị khi cần các cơn phù mạch di truyền: thử nghiệm giai đoạn 3 đa trung tâm, ngẫu nhiên, mù đôi, đối chứng giả dược, thiết kế chéo và các bằng chứng liên quan https://news.medxy.ai/oral-deucrictibant-for-on-demand-treatment-of-hereditary-angioedema-attacks-a-phase-3-multicentre-randomised-double-blind-placebo-controlled-crossover-trial-and-related-evidence/Medxy AIen2026-10-28T01:47:00-07:00Oral Deucrictibant for On-Demand Treatment of Hereditary Angioedema Attacks: A Phase 3, Multicentre, Randomised, Double-Blind, Placebo-Controlled Crossover Trial and Related Evidence https://news.medxy.ai/driving-legislative-change-for-access-to-medications-in-pediatric-inflammatory-bowel-disease/Medxy AIen2026-10-28T01:46:10-07:00Driving Legislative Change for Access to Medications in Pediatric Inflammatory Bowel Disease https://news.medxy.ai/zh/peripheral-blood-uba1-burden/Medxy AIzh2026-10-28T01:45:28-07:00外周血 UBA1 变异负荷：VEXAS 综合征中的预后新标志物——来自全国性前瞻性研究的证据 https://news.medxy.ai/ja/peripheral-uba1-variant-burden/Medxy AIja2026-10-28T01:45:02-07:00VEXAS症候群の予後予測における末梢血UBA1変異負荷：全国前向き研究から見えたもの https://news.medxy.ai/vi/uba1-variant-burden-vexas-prognosis/Medxy AIvi2026-10-28T01:44:34-07:00Tải lượng biến thể UBA1 trong máu ngoại vi như một dấu ấn tiên lượng trong hội chứng VEXAS: dữ liệu từ nghiên cứu tiến cứu toàn quốc https://news.medxy.ai/peripheral-blood-uba1-variant-burden-as-a-prognostic-biomarker-in-vexas-syndrome-insights-from-a-nationwide-prospective-study/Medxy AIen2026-10-28T01:44:10-07:00Peripheral Blood UBA1 Variant Burden as a Prognostic Biomarker in VEXAS Syndrome: Insights from a Nationwide Prospective Study https://news.medxy.ai/zh/race-neutral-egfr-and-kidney-transplant-equity/Medxy AIzh2026-10-28T01:43:29-07:00基于种族中立eGFR的肾移植公平性：某中心对黑人患者的早期影响 https://news.medxy.ai/ja/race-neutral-egfr-and-kidney-transplant-equity-early-impacts-on-black-patients/Medxy AIja2026-10-28T01:43:03-07:00人種を考慮しないeGFRと腎移植の公平性：単一施設における黒人患者への初期の影響 https://news.medxy.ai/race-neutral-egfr-and-kidney-transplant-equity-early-impacts-on-black-patients-at-a-single-center/Medxy AIen2026-10-28T01:42:09-07:00Race-Neutral eGFR and Kidney Transplant Equity: Early Impacts on Black Patients at a Single Center https://news.medxy.ai/zh/qy201-atopic-dermatitis/Medxy AIzh2026-10-28T01:41:27-07:00口服双重 JAK1/TYK2 抑制剂 QY201 在中重度特应性皮炎中疗效与安全性可期：2 期剂量探索试验结果 https://news.medxy.ai/ja/qy201-atopic-dermatitis-2/Medxy AIja2026-10-28T01:40:59-07:00中等症から重症アトピー性皮膚炎に有望な効果と安全性を示したQY201：JAK1/TYK2二重阻害薬の第2相用量探索試験 https://news.medxy.ai/vi/qy201-jak1-tyk2-atopic-dermatitis/Medxy AIvi2026-10-28T01:40:31-07:00QY201 – chất ức chế kép JAK1/TYK2 cho thấy hiệu quả và độ an toàn đầy hứa hẹn trong viêm da cơ địa mức độ vừa đến nặng: Kết quả thử nghiệm xác định liều pha 2 https://news.medxy.ai/qy201-a-dual-jak1-tyk2-inhibitor-shows-promising-efficacy-and-safety-in-moderate-to-severe-atopic-dermatitis-phase-2-dose-finding-trial-results/Medxy AIen2026-10-28T01:40:07-07:00QY201, a Dual JAK1/TYK2 Inhibitor, Shows Promising Efficacy and Safety in Moderate-to-Severe Atopic Dermatitis: Phase 2 Dose-Finding Trial Results https://news.medxy.ai/zh/orthopedic-regeneration-frontier/Medxy AIzh2026-10-28T01:39:26-07:00整形外科迎来新前沿：部分细胞重编程的再生潜力 https://news.medxy.ai/ja/new-era-plastic-surgery-cell-reprogramming/Medxy AIja2026-10-28T01:39:00-07:00形成外科が新たな転換点へ：細胞の部分的リプログラミングの可能性 https://news.medxy.ai/vi/new-era-plastic-surgery/Medxy AIvi2026-10-28T01:38:27-07:00Phẫu thuật tạo hình trước bước ngoặt mới: tiềm năng của tái lập trình tế bào một phần https://news.medxy.ai/revolutionizing-plastic-surgery-the-promise-of-partial-cellular-reprogramming/Medxy AIen2026-10-28T01:37:58-07:00Revolutionizing Plastic Surgery: The Promise of Partial Cellular Reprogramming https://news.medxy.ai/zh/humanism-under-pressure/Medxy AIzh2026-10-27T04:37:20-07:00在压力中守护人文：医疗体系重压下的人文实践培育 https://news.medxy.ai/ja/protecting-humanity-in-healthcare/Medxy AIja2026-10-27T04:36:58-07:00医療制度の圧力の中で人間性を守る：ヒューマニスティック・プラクティスを育むために https://news.medxy.ai/vi/balancing-efficiency-and-humanity/Medxy AIvi2026-10-27T04:36:33-07:00Cân bằng giữa hiệu quả và nhân văn: Nuôi dưỡng thực hành lấy con người làm trung tâm trong bối cảnh áp lực hệ thống y tế https://news.medxy.ai/navigating-the-balance-fostering-humanistic-practice-amidst-healthcare-system-pressures/Medxy AIen2026-10-27T04:36:14-07:00Navigating the Balance: Fostering Humanistic Practice Amidst Healthcare System Pressures https://news.medxy.ai/zh/targeting-il6-receptor-signaling/Medxy AIzh2026-10-27T04:35:39-07:00靶向IL-6受体信号：增强细胞毒性CD4+ T细胞并改善细胞免疫治疗结局 https://news.medxy.ai/ja/il-6-targeted-immunotherapy/Medxy AIja2026-10-27T04:35:09-07:00IL-6受容体シグナルを標的とすることで、細胞傷害性CD4+ T細胞が増強され、細胞性免疫療法後の転帰が改善する https://news.medxy.ai/vi/targeting-il-6-signaling/Medxy AIvi2026-10-27T04:34:36-07:00Nhắm vào tín hiệu thụ thể IL-6 để tăng cường tế bào T CD4+ gây độc và cải thiện kết cục sau liệu pháp miễn dịch tế bào https://news.medxy.ai/targeting-il-6-receptor-signaling-enhances-cytolytic-cd4-t-cells-and-improves-outcomes-after-cellular-immunotherapy/Medxy AIen2026-10-27T04:34:07-07:00Targeting IL-6 Receptor Signaling Enhances Cytolytic CD4+ T Cells and Improves Outcomes After Cellular Immunotherapy https://news.medxy.ai/zh/global-icu-resources-organization-variations/Medxy AIzh2026-10-27T04:33:21-07:00全球重症监护病房资源与组织差异：ISOREA 调查带来的启示 https://news.medxy.ai/ja/global-icu-disparities/Medxy AIja2026-10-27T04:32:51-07:00世界のICU資源と組織体制にみる格差：ISOREA調査からの知見 https://news.medxy.ai/vi/global-icu-resources/Medxy AIvi2026-10-27T04:32:20-07:00Chênh lệch toàn cầu về nguồn lực và tổ chức ICU: Góc nhìn từ khảo sát ISOREA https://news.medxy.ai/global-disparities-in-intensive-care-unit-resources-and-organization-insights-from-the-isorea-survey/Medxy AIen2026-10-27T04:31:56-07:00Global Disparities in Intensive Care Unit Resources and Organization: Insights from the ISOREA Survey https://news.medxy.ai/zh/quantitative-vascular-severity-score/Medxy AIzh2026-10-27T04:31:17-07:00定量血管严重程度评分为早产儿视网膜病变的跨人群研究提供新视角 https://news.medxy.ai/ja/ai-retinopathy-severity-assessment/Medxy AIja2026-10-27T04:30:51-07:00AIによる血管重症度評価で広がる未熟児網膜症の理解：多様な集団で見えた新たな差異 https://news.medxy.ai/vi/vascular-severity-scoring-in-retinopathy-of-prematurity/Medxy AIvi2026-10-27T04:30:18-07:00Điểm số định lượng mức độ nặng mạch máu: bước tiến mới trong hiểu biết về bệnh võng mạc trẻ sinh non ở nhiều quần thể https://news.medxy.ai/quantitative-vascular-severity-scoring-enhances-insights-into-retinopathy-of-prematurity-across-diverse-populations/Medxy AIen2026-10-27T04:29:51-07:00Quantitative Vascular Severity Scoring Enhances Insights into Retinopathy of Prematurity Across Diverse Populations https://news.medxy.ai/ja/swallowing-changes-early-treatment/Medxy AIja2026-10-27T04:29:09-07:00頭頸部がん関連リンパ浮腫の早期治療で嚥下はどう変わるのか https://news.medxy.ai/vi/improve-swallowing-function/Medxy AIvi2026-10-27T04:28:44-07:00Cải thiện chức năng nuốt sau điều trị sớm phù bạch huyết liên quan đến ung thư đầu và cổ https://news.medxy.ai/swallowing-outcomes-following-early-treatment-of-head-and-neck-cancer-related-lymphedema/Medxy AIen2026-10-27T04:28:24-07:00Swallowing Outcomes Following Early Treatment of Head and Neck Cancer-Related Lymphedema https://news.medxy.ai/zh/neoadjuvant-therapy-pancreatic-cancer-prognosis/Medxy AIzh2026-10-27T04:27:48-07:00新辅助治疗如何重塑胰腺导管腺癌预后评估：生存预测因子的差异化应用 https://news.medxy.ai/ja/pancreatic-cancer-prognosis-prediction/Medxy AIja2026-10-27T04:27:19-07:00膵管腺癌の予後予測を治療背景で最適化する：術前治療が生存予測因子に及ぼす影響 https://news.medxy.ai/vi/neoadjuvant-therapy-for-pancreatic-cancer-prognosis/Medxy AIvi2026-10-27T04:26:49-07:00Tối ưu hóa dự báo tiên lượng ung thư biểu mô tuyến ống tụy dựa trên bối cảnh điều trị: Ảnh hưởng của điều trị trước phẫu thuật đối với các yếu tố dự báo sống còn https://news.medxy.ai/tailoring-prognostication-in-pancreatic-ductal-adenocarcinoma-impact-of-neoadjuvant-therapy-on-survival-predictors/Medxy AIen2026-10-27T04:26:21-07:00Tailoring Prognostication in Pancreatic Ductal Adenocarcinoma: Impact of Neoadjuvant Therapy on Survival Predictors https://news.medxy.ai/zh/hpv-vaccine-screening/Medxy AIzh2026-10-27T04:25:31-07:00HPV 疫苗接种年轻女性的细胞学与高危型 HPV 检测评估：来自苏格兰前瞻性研究的启示 https://news.medxy.ai/ja/cervical-screening-evaluation/Medxy AIja2026-10-27T04:25:00-07:00HPVワクチン接種若年女性における細胞診と高リスクHPV検査の評価：スコットランド前向き研究からの示唆 https://news.medxy.ai/vi/hpv-and-cervical-screening-evaluation/Medxy AIvi2026-10-27T04:24:23-07:00Đánh giá xét nghiệm tế bào học và xét nghiệm HPV nguy cơ cao ở phụ nữ trẻ đã tiêm vắc-xin HPV: Những gợi ý từ một nghiên cứu tiến cứu tại Scotland https://news.medxy.ai/evaluating-cytology-and-high-risk-hpv-testing-in-hpv-vaccinated-young-women-insights-from-a-scottish-prospective-study/Medxy AIen2026-10-27T04:23:53-07:00Evaluating Cytology and High-Risk HPV Testing in HPV-Vaccinated Young Women: Insights from a Scottish Prospective Study https://news.medxy.ai/zh/systemic-fluoroquinolones-neuropathy-risk/Medxy AIzh2026-10-27T04:23:09-07:00系统性氟喹诺酮类药物与周围神经病变风险：证据综述及临床启示 https://news.medxy.ai/ja/systemic-fluoroquinolone-neuropathy-risk/Medxy AIja2026-10-27T04:22:29-07:00全身性フルオロキノロン系抗菌薬と末梢神経障害リスク：最新エビデンスと臨床的示唆 https://news.medxy.ai/vi/systemic-fluoroquinolones-neuropathy-risk-2/Medxy AIvi2026-10-27T04:21:45-07:00Fluoroquinolone toàn thân và nguy cơ bệnh lý thần kinh ngoại biên: Tổng quan bằng chứng toàn diện và hàm ý lâm sàng https://news.medxy.ai/systemic-fluoroquinolones-and-peripheral-neuropathy-risk-comprehensive-evidence-review-and-clinical-implications/Medxy AIen2026-10-27T04:21:06-07:00Systemic Fluoroquinolones and Peripheral Neuropathy Risk: Comprehensive Evidence Review and Clinical Implications https://news.medxy.ai/a-recipe-for-better-diabetes-management-embracing-the-dash4d-dietary-pattern/Medxy AIen2026-10-27T04:20:09-07:00A Recipe for Better Diabetes Management: Embracing the DASH4D Dietary Pattern https://news.medxy.ai/zh/familial-hypercholesterolemia-thymus-aging/Medxy AIzh2026-10-27T04:19:26-07:00中国大型队列揭示：家族性高胆固醇血症可加速胸腺衰老 https://news.medxy.ai/ja/familial-hypercholesterolemia-accelerates-thymic-aging/Medxy AIja2026-10-27T04:18:53-07:00家族性高コレステロール血症は胸腺老化を加速する：大規模中国コホートから得られた知見 https://news.medxy.ai/vi/familial-hypercholesterolemia-thymus-aging-2/Medxy AIvi2026-10-27T04:18:18-07:00Ảnh hưởng của tăng cholesterol máu gia đình lên lão hóa tuyến ức: bằng chứng từ một đoàn hệ lớn tại Trung Quốc https://news.medxy.ai/impact-of-familial-hypercholesterolaemia-on-thymic-ageing-insights-from-a-large-chinese-cohort/Medxy AIen2026-10-27T04:17:51-07:00Impact of Familial Hypercholesterolaemia on Thymic Ageing: Insights from a Large Chinese Cohort https://news.medxy.ai/zh/medial-meniscus-root-repair/Medxy AIzh2026-10-27T04:17:01-07:00内侧半月板后根修复联合半月板中心化：兔模型揭示更佳愈合与区域性软骨保护 https://news.medxy.ai/ja/medial-meniscus-root-repair-centralization/Medxy AIja2026-10-27T04:16:29-07:00内側半月板後根修復におけるcentralization併用の効果：ウサギモデルで示された区域特異的軟骨保護と治癒促進 https://news.medxy.ai/vi/medial-meniscus-root-repair-2/Medxy AIvi2026-10-27T04:15:56-07:00Sửa chữa chân sau sụn chêm trong kết hợp trung tâm hóa: cải thiện liền thương và bảo vệ sụn theo từng vùng trong mô hình thỏ https://news.medxy.ai/enhanced-healing-and-zone-specific-cartilage-protection-with-concomitant-meniscal-centralization-in-medial-meniscus-posterior-root-repair-insights-from-a-rabbit-model/Medxy AIen2026-10-27T04:15:25-07:00Enhanced Healing and Zone-Specific Cartilage Protection With Concomitant Meniscal Centralization in Medial Meniscus Posterior Root Repair: Insights From a Rabbit Model https://news.medxy.ai/zh/loneliness-spinal-cord-injury/Medxy AIzh2026-10-27T04:14:44-07:00创伤性脊髓损伤中的孤独感：心理社会相关因素及临床启示 https://news.medxy.ai/ja/loneliness-spinal-cord-injury-2/Medxy AIja2026-10-27T04:14:22-07:00外傷性脊髄損傷における孤独感を読み解く：心理社会的関連因子と臨床的意義 https://news.medxy.ai/vi/loneliness-after-spinal-cord-injury/Medxy AIvi2026-10-27T04:13:55-07:00Hiểu về cô đơn sau chấn thương tủy sống: Các tương quan tâm lý – xã hội và ý nghĩa lâm sàng https://news.medxy.ai/understanding-loneliness-in-traumatic-spinal-cord-injury-psychosocial-correlates-and-clinical-implications/Medxy AIen2026-10-27T04:13:30-07:00Understanding Loneliness in Traumatic Spinal Cord Injury: Psychosocial Correlates and Clinical Implications https://news.medxy.ai/zh/peri-implantitis-surgery-10-year-outcomes/Medxy AIzh2026-10-27T04:12:51-07:00应用牛源性骨矿物质/胶原基质、EMD及多西环素进行种植体周围炎手术的10年疗效 https://news.medxy.ai/ja/10-year-peri-implantitis-outcomes/Medxy AIja2026-10-27T04:12:25-07:00牛由来骨ミネラル・コラーゲンマトリックスとEMD・ドキシサイクリンによるインプラント周囲炎手術の10年成績 https://news.medxy.ai/vi/10-year-peri-implantitis-surgery-outcomes/Medxy AIvi2026-10-27T04:11:53-07:00Kết quả 10 năm của can thiệp phẫu thuật viêm quanh implant bằng khoáng xương bò khử protein, dẫn xuất ma trận men và doxycycline https://news.medxy.ai/ten-year-outcomes-of-surgical-intervention-for-peri-implantitis-using-bovine-bone-collagen-matrix-enamel-matrix-derivative-and-doxycycline/Medxy AIen2026-10-27T04:11:25-07:00Ten-Year Outcomes of Surgical Intervention for Peri-Implantitis Using Bovine Bone Collagen Matrix, Enamel Matrix Derivative, and Doxycycline https://news.medxy.ai/zh/giredestrant-everolimus-breast-cancer/Medxy AIzh2026-10-27T04:10:43-07:00ER 阳性、HER2 阴性晚期乳腺癌治疗再进阶：giredestrant 联合 everolimus 的疗效解析 https://news.medxy.ai/ja/advancing-breast-cancer-treatment/Medxy AIja2026-10-27T04:10:18-07:00ER陽性・HER2陰性進行乳癌治療を前進させる：Giredestrant＋Everolimusの有効性 https://news.medxy.ai/vi/advanced-breast-cancer-treatment/Medxy AIvi2026-10-27T04:09:44-07:00Ung thư vú tiến triển ER dương tính, HER2 âm tính: giredestrant phối hợp everolimus cho thấy hiệu quả vượt trội https://news.medxy.ai/advancing-treatment-in-er-positive-her2-negative-advanced-breast-cancer-efficacy-of-giredestrant-plus-everolimus/Medxy AIen2026-10-27T04:09:15-07:00Advancing Treatment in ER-Positive, HER2-Negative Advanced Breast Cancer: Efficacy of Giredestrant Plus Everolimus https://news.medxy.ai/zh/ai-assisted-melanoma-detection/Medxy AIzh2026-10-27T04:05:54-07:00AI辅助皮肤镜如何提升恶性雀斑样痣识别：面部色素性病变的临床读片研究 https://news.medxy.ai/vi/ai-assisted-dermoscopy-lentigo-maligna-detection/Medxy AIvi2026-10-27T04:03:57-07:00AI hỗ trợ dermoscopy giúp nâng cao phát hiện lentigo maligna ở tổn thương sắc tố vùng mặt https://news.medxy.ai/enhancing-lentigo-maligna-detection-with-ai-assisted-dermoscopy-a-clinical-reader-study-on-facial-pigmented-lesions/Medxy AIen2026-10-27T04:02:40-07:00Enhancing Lentigo Maligna Detection with AI-Assisted Dermoscopy: A Clinical Reader Study on Facial Pigmented Lesions https://news.medxy.ai/zh/weight-loss-breast-reduction/Medxy AIzh2026-10-27T04:01:58-07:00肥胖患者乳房缩小成形术前显著减重对术后结局及医疗利用的影响 https://news.medxy.ai/vi/preoperative-weight-loss-breast-reduction-outcomes/Medxy AIvi2026-10-27T04:01:01-07:00Giảm cân đáng kể trước mổ ảnh hưởng thế nào đến kết cục sau phẫu thuật và sử dụng dịch vụ y tế sau thu nhỏ tuyến vú ở bệnh nhân béo phì https://news.medxy.ai/impact-of-substantial-preoperative-weight-loss-on-postoperative-outcomes-and-healthcare-utilization-following-reduction-mammoplasty-in-obese-patients/Medxy AIen2026-10-27T04:00:27-07:00Impact of Substantial Preoperative Weight Loss on Postoperative Outcomes and Healthcare Utilization Following Reduction Mammoplasty in Obese Patients https://news.medxy.ai/zh/persistent-mental-health-distress/Medxy AIzh2026-10-27T03:59:39-07:00ICU脓毒症幸存者照护者的持续性精神健康困扰：与患者重症监护后综合征的关联 https://news.medxy.ai/ja/persistent-mental-health-distress-in-spesis/Medxy AIja2026-10-27T03:59:19-07:00ICUでの敗血症から生還した患者の家族介護者が抱える持続的なメンタルヘルス上の課題：患者の「集中治療後症候群（PICS）」との関連 https://news.medxy.ai/vi/persistent-mental-health-challenges-among-caregivers-of-icu-sepsis-survivors/Medxy AIvi2026-10-27T03:58:52-07:00Những thách thức dai dẳng về sức khỏe tâm thần ở người chăm sóc bệnh nhân sống sót sau nhiễm khuẩn huyết tại khoa hồi sức tích cực (ICU): Mối liên hệ với hội chứng sau hồi sức tích cực ở bệnh nhân https://news.medxy.ai/persistent-mental-health-challenges-among-caregivers-of-icu-sepsis-survivors-links-to-patient-post-intensive-care-syndrome/Medxy AIen2026-10-27T03:58:30-07:00Persistent Mental Health Challenges Among Caregivers of ICU Sepsis Survivors: Links to Patient Post-Intensive Care Syndrome https://news.medxy.ai/ja/home-rehabilitation-disparities/Medxy AIja2026-10-27T03:57:54-07:00高齢者の外傷性脳損傷後リハビリテーションにおける在宅・地域サービス利用の格差 https://news.medxy.ai/vi/post-rehabilitation-care-gap/Medxy AIvi2026-10-27T03:57:28-07:00Khoảng trống trong tiếp cận dịch vụ tại nhà và dựa vào cộng đồng sau phục hồi chức năng nội trú vì chấn thương sọ não ở người cao tuổi https://news.medxy.ai/gaps-in-access-to-home-and-community-based-services-following-inpatient-rehabilitation-for-traumatic-brain-injury-in-older-adults/Medxy AIen2026-10-27T03:57:10-07:00Gaps in Access to Home and Community-Based Services Following Inpatient Rehabilitation for Traumatic Brain Injury in Older Adults https://news.medxy.ai/zh/venetoclax-plus-azacitidine-in-younger-adults-with-acute-myeloid-leukemia/Medxy AIzh2026-10-27T03:56:34-07:00维奈托克联合阿扎胞苷治疗急性髓系白血病年轻患者：超越历史对比的循证证据演进 https://news.medxy.ai/ja/venetoclax-azacitidine-aml/Medxy AIja2026-10-27T03:55:56-07:00急性骨髄性白血病の若年成人における Venetoclax＋Azacitidine：歴史的比較を超えて進化するエビデンス https://news.medxy.ai/vi/venetoclax-plus-azacitidine-in-younger-adults-with-acute-myeloid-leukemia-evolving-evidence-beyond-historical-comparisons-2/Medxy AIvi2026-10-27T03:55:17-07:00Venetoclax kết hợp Azacitidine ở người trưởng thành trẻ tuổi mắc bệnh bạch cầu cấp dòng tủy: Bằng chứng đang phát triển vượt xa các so sánh dựa trên dữ liệu lịch sử https://news.medxy.ai/venetoclax-plus-azacitidine-in-younger-adults-with-acute-myeloid-leukemia-evolving-evidence-beyond-historical-comparisons/Medxy AIen2026-10-27T03:54:41-07:00Venetoclax Plus Azacitidine in Younger Adults with Acute Myeloid Leukemia: Evolving Evidence Beyond Historical Comparisons https://news.medxy.ai/zh/natural-history-treatment-survival-and-causes-of-mortality-in-patients/Medxy AIzh2026-10-27T03:53:35-07:00亚实性结节及磨玻璃结节患者的自然病程、治疗、生存情况及死亡原因：一项全面的临床综述 https://news.medxy.ai/ja/subsolid-nodule-review/Medxy AIja2026-10-27T03:52:56-07:00亜実質性結節とすりガラス陰影の自然史・治療・予後・死亡原因を総覧する臨床レビュー https://news.medxy.ai/vi/natural-history-treatment-survival-and-causes-of-mortality-in-patients-with-subsolid-and-ground-glass-nodules/Medxy AIvi2026-10-27T03:52:10-07:00Diễn tiến tự nhiên, điều trị, tiên lượng và nguyên nhân tử vong liên quan đến các nốt dạng đặc một phần (subsolid nodules) và tổn thương dạng kính mờ (ground-glass opacities) https://news.medxy.ai/natural-history-treatment-survival-and-causes-of-mortality-in-patients-with-subsolid-and-ground-glass-nodules-a-comprehensive-clinical-review/Medxy AIen2026-10-27T03:51:40-07:00Natural History, Treatment, Survival, and Causes of Mortality in Patients With Subsolid and Ground-Glass Nodules: A Comprehensive Clinical Review https://news.medxy.ai/ja/ophthalmic-surgery-cost-analysis/Medxy AIja2026-10-27T02:50:29-07:00外来眼科手術のコスト分析 https://news.medxy.ai/vi/outpatient-ophthalmic-procedure-costs/Medxy AIvi2026-10-27T02:50:04-07:00Phân tích chi phí các thủ thuật nhãn khoa ngoại trú https://news.medxy.ai/cost-analysis-of-outpatient-ophthalmic-procedures/Medxy AIen2026-10-27T02:49:44-07:00Cost Analysis of Outpatient Ophthalmic Procedures https://news.medxy.ai/zh/delayed-wound-healing-predictors/Medxy AIzh2026-10-27T02:49:06-07:00改良 Sommerlad-Furlow 腭成形术后伤口愈合延迟的预测因素与结局：大型队列研究的启示 https://news.medxy.ai/ja/predicting-delayed-wound-healing/Medxy AIja2026-10-27T02:48:38-07:00修正Sommerlad-Furlow口蓋形成術後の創傷治癒遅延を予測する因子と転帰：大規模コホート研究からの知見 https://news.medxy.ai/vi/predictors-of-delayed-healing/Medxy AIvi2026-10-27T02:48:07-07:00Các yếu tố dự báo và kết cục của liền vết thương chậm sau phẫu thuật tạo hình khẩu cái Sommerlad-Furlow cải tiến: phân tích từ một nghiên cứu đoàn hệ lớn https://news.medxy.ai/predictors-and-outcomes-of-delayed-wound-healing-following-modified-sommerlad-furlow-palatoplasty-insights-from-a-large-cohort-study/Medxy AIen2026-10-27T02:47:41-07:00Predictors and Outcomes of Delayed Wound Healing Following Modified Sommerlad-Furlow Palatoplasty: Insights from a Large Cohort Study https://news.medxy.ai/zh/bile-duct-cancer-staging/Medxy AIzh2026-10-27T02:46:59-07:00胆道癌分期的新突破：基于浸润深度的胆囊管汇合部肿瘤分类 https://news.medxy.ai/ja/biliary-cancer-staging-redefinition/Medxy AIja2026-10-27T02:46:32-07:00胆道癌の病期分類を再定義する：胆嚢管接合部における深達度ベース腫瘍分類 https://news.medxy.ai/vi/gallbladder-tumor-staging/Medxy AIvi2026-10-27T02:46:04-07:00Bước tiến mới trong giai đoạn hóa ung thư đường mật: Phân loại khối u dựa trên độ sâu tại chỗ nối ống túi mật https://news.medxy.ai/revolutionizing-biliary-tract-cancer-staging-depth-based-tumor-classification-at-the-cystic-duct-junction/Medxy AIen2026-10-27T02:45:41-07:00Revolutionizing Biliary Tract Cancer Staging: Depth-Based Tumor Classification at the Cystic Duct Junction https://news.medxy.ai/zh/immunotherapy-disparities-endometrial-cancer/Medxy AIzh2026-10-27T02:45:00-07:00老年晚期子宫内膜癌免疫治疗使用不平等：NCDB分析揭示年龄与种族差异 https://news.medxy.ai/ja/immunotherapy-disparities-endometrial-cancer-2/Medxy AIja2026-10-27T02:44:36-07:00高齢の進行子宮内膜癌における免疫療法の利用格差：NCDB解析からみた示唆 https://news.medxy.ai/vi/immunotherapy-in-endometrial-cancer/Medxy AIvi2026-10-27T02:44:05-07:00Sự chênh lệch trong việc tiếp cận liệu pháp miễn dịch ở bệnh nhân cao tuổi mắc ung thư nội mạc tử cung tiến triển: Những gợi ý từ phân tích dữ liệu NCDB https://news.medxy.ai/disparities-in-immunotherapy-use-for-advanced-endometrial-cancer-among-older-adults-insights-from-ncdb-analysis/Medxy AIen2026-10-27T02:43:40-07:00Disparities in Immunotherapy Use for Advanced Endometrial Cancer Among Older Adults: Insights from NCDB Analysis